Detalhe da pesquisa
1.
SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
Circ Res
; 131(11): 926-943, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36278398
2.
A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection.
Pharmacol Res
; 199: 107029, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056513
3.
Blockade of endothelial adenosine receptor 2â¯A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition.
Pharmacol Res
; 203: 107156, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38522762
4.
Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.
Acta Pharmacol Sin
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589689
5.
A novel mouse model of familial combined hyperlipidemia and atherosclerosis.
Acta Pharmacol Sin
; 45(6): 1316-1320, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459255
6.
Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery.
Acta Pharmacol Sin
; 45(1): 23-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644131
7.
Bioactive Flavonoids in Protecting Against Endothelial Dysfunction and Atherosclerosis.
Handb Exp Pharmacol
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38755351
8.
Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models.
Eur Heart J
; 44(14): 1265-1279, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721994
9.
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.
Pharmacol Rev
; 73(3): 924-967, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088867
10.
Hutchinson-Gilford Progeria Syndrome: Cardiovascular Pathologies and Potential Therapies.
Trends Biochem Sci
; 44(7): 561-564, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036409
11.
Retraction notice to "Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway" [Arch. Biochem. Biophys. 502(2010) 112-120].
Arch Biochem Biophys
; 742: 109636, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230810
12.
Harnessing polyphenol power by targeting eNOS for vascular diseases.
Crit Rev Food Sci Nutr
; 63(14): 2093-2118, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-34553653
13.
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.
Acta Pharmacol Sin
; 44(4): 695-709, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253560
14.
Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics.
Acta Pharmacol Sin
; 44(12): 2358-2375, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550526
15.
Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6/STAT3 signaling pathway and the interplay between VSMCs and ECs.
Acta Pharmacol Sin
; 44(8): 1625-1636, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997664
16.
Endothelial-specific YY1 governs sprouting angiogenesis through directly interacting with RBPJ.
Proc Natl Acad Sci U S A
; 117(9): 4792-4801, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32075915
17.
Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases.
Inflammopharmacology
; 31(3): 1069-1093, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997729
18.
A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
Biochem Biophys Res Commun
; 622: 163-169, 2022 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868060
19.
Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE-/- mice.
Pharmacol Res
; 175: 106043, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954030
20.
Paeoniflorin prevents aberrant proliferation and differentiation of intestinal stem cells by controlling C1q release from macrophages in chronic colitis.
Pharmacol Res
; 182: 106309, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716915